FeNO-based asthma management results in faster improvement of airway hyperresponsiveness
Asthma is characterised by inflammation and respiratory symptoms. Current asthma treatment is based on severity of asthma symptoms only. Exhaled nitric oxide fraction (FeNO) is not recommended by the Global Initiative for Asthma guidelines. The aim was to compare the usefulness of a FeNO guided vers...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2018-10-01
|
| Colección: | ERJ Open Research |
| Acceso en línea: | http://openres.ersjournals.com/content/4/4/00147-2017.full |